Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

CFO Smith says Abzena's integrated offering will help the company grow

Julian Smith, chief financial officer at drug developer and pharma services  group Abzena (LON:ABZA), tells Proactive Investors the integration of two US companies acquired last year - PacificGMP and TCRS - is "progressing well".

Smith explains Abzena's integrated offering will help the company grow as customers are responding well.

He adds the licence agreement for ThioBridge is a "fantastic result for the group."

 
Meet Acal Plc and Scancell Holdings Plc at our event, London, 07 July 2016. Register here »
Why Invest In Abzena plc? Read More Here

Register here to be notified of future Abzena plc articles
View full ABZA profile

Abzena plc Timeline

Big Picture
June 14 2016
Article
December 11 2015

© Proactive Investors 2016

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.